Leading Pharmaceutical Firms Listed on Pakistan Stock Exchange by July 2025
In the bustling pharmaceutical industry of Pakistan, several companies have emerged as leaders, both in terms of market capitalization and market share. Here's a look at the current landscape.
Market Leaders
As of July 2025, GlaxoSmithKline Pakistan Limited (GLAXO) takes the lead with a market capitalization of $438 million, making it the largest pharmaceutical company by market cap on the Pakistan Stock Exchange (PSX). Abbott Laboratories Pakistan Limited (ABOT) also ranks amongst the top-tier players.
The pharmaceutical sector in Pakistan boasts a balanced presence of national/local companies and multinational corporations. Other notable companies include The Searle Company Limited, Martin Dow Ltd., Hilton, OBS, High-Q International, and Haleon Pakistan Ltd..
Notable Acquisitions and Expansions
Earlier this year, Ferozsons announced it was exploring a potential acquisition of Barrett Hodgson Pakistan Pvt Limited in collaboration with a consortium of leading Pakistani business groups.
In a significant move, a consortium led by Packages Limited acquired 52.87% shares from Sanofi Foreign Participations B.V. and changed the name of Hoechst Pakistan Limited from Sanofi-aventis Pakistan Limited in September 2023.
Last year, CPHL entered into a strategic partnership with Mersi Farma to establish API manufacturing facilities and expand its nutraceutical market in Indonesia. HPL also announced plans to establish a subsidiary in the United Arab Emirates (UAE).
Market Capitalizations
- Macter International Limited (PSX: MACTER) has a market capitalization of $62 million.
- The Searle Company Limited (PSX: SEARL) has a market capitalization of $167 million, with International Brands (Private) Limited holding 50.25% of its outstanding shares.
- Hoechst Pakistan Limited (PSX: HPL) has a market capitalization of $105 million.
- Citi Pharma Limited (PSX: CPHL) was listed on the PSX in 2021 and has a market capitalization of $66 million.
- Ferozsons Laboratories Limited has a market capitalization of $60 million.
Growth and Potential
Pakistan's pharmaceutical exports reached a high in FY25, indicating growth and expansion potential in this sector. The industry's dominance on the PSX, along with significant market shares in domestic and export markets, makes it a promising area for investment.
[1]: Source 1 [2]: Source 2 [3]: Source 3
- In the midst of Pakistan's booming pharmaceutical industry, GlaxoSmithKline Pakistan Limited (GLAXO) holds the highest market capitalization, standing at $438 million, as of July 2025.
- The pharmaceutical sector in Pakistan is diverse, encompassing national/local companies and multinational corporations, with Abbott Laboratories Pakistan Limited (ABOT) also ranking among the top players.
- Other prominent companies in the sector include The Searle Company Limited, Martin Dow Ltd., Hilton, OBS, High-Q International, and Haleon Pakistan Ltd.
- Ferozsons has been exploring a potential acquisition of Barrett Hodgson Pakistan Pvt Limited, collaborating with a consortium of leading Pakistani business groups.
- In a notable move, a consortium led by Packages Limited acquired 52.87% shares from Sanofi Foreign Participations B.V., renaming Hoechst Pakistan Limited from Sanofi-aventis Pakistan Limited in September 2023.
- Last year, CPHL entered into a strategic partnership with Mersi Farma to establish API manufacturing facilities in Indonesia and expand its nutraceutical market, while HPL planned to establish a subsidiary in the United Arab Emirates (UAE).
- With significant growth in pharmaceutical exports, Pakistan's industry stands as a promising area for investment, demonstrating potential for both domestic and international investments in finance and business, particularly in the health-and-wellness, medical-conditions, and science sectors. [1], [2], [3]
